Affinity Asset Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7M Buy
95,000
+65,000
+217% +$14.6M 1.27% 29
2025
Q4
$6.4M Buy
+30,000
New +$6.2M 0.46% 57
2024
Q1
Sell
-20,000
Closed -$2.52M 104
2023
Q4
$2.52M Sell
20,000
-26,400
-57% -$2.63M 0.5% 53
2023
Q3
$4.34M Sell
46,400
-11,360
-20% -$1.06M 1.42% 28
2023
Q2
$5.16M Buy
57,760
+17,760
+44% +$1.55M 2.03% 19
2023
Q1
$4.29M Sell
40,000
-30,997
-44% -$3.55M 1.65% 24
2022
Q4
$8.67M Sell
70,997
-29,003
-29% -$3.37M 3.97% 5
2022
Q3
$10.3M Sell
100,000
-25,087
-20% -$2.38M 4.76% 8
2022
Q2
$11.6M Buy
125,087
+5,087
+4% +$479K 6.37% 5
2022
Q1
$14.1M Buy
+120,000
New +$13.9M 5.58% 5
2021
Q4
Sell
-35,910
Closed -$5.72M 57
2021
Q3
$5.72M Buy
35,910
+15,910
+80% +$2.18M 2.28% 17
2021
Q2
$2.63M Hold
20,000
1.25% 27
2021
Q1
$2.58M Buy
20,000
+10,000
+100% +$1.52M 1.26% 31
2020
Q4
$1.67M Buy
+10,000
New +$1.65M 1.03% 31

Other funds holding ASND